Table 2.
SF-36 scores in BFB+ and BFB−.
| SF-36 | ||||||
|---|---|---|---|---|---|---|
| Group | Check Point | Media | SD | Median | Range | p |
| BFB+ | Pre-treatment | 42.98 | 2.44 | 42 | 41–47 | |
| Post-treatment 3 months | 78.27 | 13.02 | 85 | 51–92 | 0.0092 | |
| Post-treatment 6 months | 78.31 | 13.40 | 85 | 49–92 | ||
| Post-treatment 12 months | 75.72 | 12.81 | 81 | 47–90 | ||
| Post-treatment average | 77.29 | 13.20 | 84 | 51.89 | ||
| BFB+ success | Pre-treatment | 42.81 | 2.66 | 41 | 41–47 | |
| Post-treatment 3 months | 85.38 | 3.51 | 86 | 77–92 | 0.2284 | |
| Post-treatment 6 months | 85.52 | 4.16 | 86 | 76–92 | ||
| Post-treatment 12 months | 82.08 | 3.84 | 81 | 73–90 | ||
| Post-treatment average | 84.55 | 3.15 | 85 | 78–89 | ||
| BFB+ failure | Pre-treatment | 43.50 | 1.57 | 43.5 | 42–45 | |
| Post-treatment 3 months | 56.92 | 4.68 | 56.5 | 51–62 | 0.8499 | |
| Post-treatment 6 months | 56.67 | 5.50 | 57 | 49–62 | ||
| Post-treatment 12 months | 52.80 | 4.21 | 53.5 | 47–58 | ||
| Post-treatment average | 55.50 | 4.7 | 55.50 | 51–60 | ||
| BFB− | Pre-treatment | 47.96 | 6.17 | 45 | 40–58 | |
| Post-treatment 3 months | 73.92 | 15.97 | 83 | 48.95 | 0.0375 | |
| Post-treatment 6 months | 72.25 | 15.69 | 81 | 48.90 | ||
| Post-treatment 12 months | 69.76 | 16.38 | 80 | 46–87 | ||
| Post-treatment average | 71.79 | 15.79 | 82 | 50–82 | ||
| BFB− success | Pre-treatment | 48.20 | 5.78 | 45 | 40–58 | |
| Post-treatment 3 months | 86.90 | 3.58 | 87 | 80–95 | 0.1028 | |
| Post-treatment 6 months | 85 | 3.23 | 85 | 78–90 | ||
| Post-treatment 12 months | 83.27 | 2.43 | 83 | 78–87 | ||
| Post-treatment average | 84.77 | 2.44 | 85 | 80–88 | ||
| BFB− failure | Pre-treatment | 47.61 | 6.75 | 45 | 41–58 | |
| Post-treatment 3 months | 55.48 | 3.45 | 55 | 48–61 | 0.2185 | |
| Post-treatment 6 months | 54.16 | 3.91 | 53 | 48–61 | ||
| Post-treatment 12 months | 50.58 | 2.40 | 50 | 46–55 | ||
| Post-treatment average | 53.35 | 2.85 | 52 | 50–59 | ||
SF-36: value in the answers to the quality of life questionnaire SF-36. SD: standard deviation. BFB+: group of patients who received adjuvant biofeedback of the pelvic floor; BFB−: group of patients who did not receive biofeedback of the pelvic floor.